Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 16492032 | OLIGONUCLEOTIDES AND METHOD FOR THE DETECTION AND TYPING OF HUMAN PAPILLOMAVIRUS | December 2020 | November 2023 | Abandon | 50 | 0 | 1 | No | No |
| 17048244 | PRIMER SET FOR USE IN DETECTION OF CANDIDA AURIS, CANDIDA AURIS DETECTION KIT, AND CANDIDA AURIS DETECTION METHOD | October 2020 | April 2023 | Allow | 30 | 2 | 1 | Yes | No |
| 17039865 | PROGRAMMABLE NUCLEASE COMPOSITIONS AND METHODS OF USE THEREOF | September 2020 | March 2024 | Abandon | 42 | 0 | 1 | No | No |
| 17003790 | TRANSCRIPTOME SEQUENCING THROUGH RANDOM LIGATION | August 2020 | March 2024 | Allow | 43 | 4 | 0 | Yes | No |
| 16971513 | PRIMER SET FOR DETECTING TRICHOPHYTON GENE BY LAMP METHOD, KIT INCLUDING SAME, AND METHOD FOR DETECTING TRICHOPHYTON USING SAME | August 2020 | October 2022 | Allow | 26 | 2 | 1 | Yes | No |
| 16967659 | REAGENT AND METHOD FOR FLUORESCENCE QUANTITATIVE REAL-TIME PCR DETECTION OF RCL | August 2020 | February 2023 | Allow | 30 | 1 | 1 | No | No |
| 16966839 | TARGET NUCLEIC ACID-DETECTING METHOD USING THREE-WAY JUNCTION STRUCTURE-INDUCED ISOTHERMAL AMPLIFICATION | July 2020 | May 2024 | Abandon | 46 | 5 | 1 | Yes | No |
| 16966778 | TARGET NUCLEIC ACID-DETECTING METHOD USING HAIRPIN PROBE-ASSISTED ISOTHERMAL PROBE AMPLIFICATION | July 2020 | August 2024 | Abandon | 48 | 5 | 1 | No | No |
| 16772714 | Method For The Simultaneous Detection And Quantification Of Epstein-Barr Virus, Cytomegalovirus, Human Herpesvirus 6, Human Herpesvirus 7 and Kaposi's Sarcoma Virus Using A Multiplex, Real-Time Polymerase Chain Reaction | July 2020 | May 2024 | Allow | 47 | 4 | 0 | Yes | No |
| 16963298 | METHODS, CONJUGATES AND SYSTEMS | July 2020 | November 2023 | Abandon | 40 | 0 | 1 | No | No |
| 16924204 | METHODS FOR LOADING A DIGITAL PCR CHIP | July 2020 | April 2024 | Abandon | 45 | 2 | 0 | Yes | Yes |
| 16958535 | METHOD FOR QUICKLY HOMOGENIZING CIRCULAR DNA SAMPLES | June 2020 | May 2022 | Abandon | 22 | 1 | 1 | No | No |
| 15733317 | METHOD FOR RAPIDLY PREPARING SANGER SEQUENCING TEMPLATE | June 2020 | April 2022 | Abandon | 22 | 1 | 0 | No | No |
| 16946376 | METHOD FOR SELECTION OF CORRECT NUCLEIC ACIDS | June 2020 | March 2022 | Abandon | 21 | 1 | 0 | No | No |
| 16892638 | METHOD FOR ANALYZING NUCLEIC ACID SEQUENCE | June 2020 | November 2022 | Allow | 30 | 2 | 0 | No | Yes |
| 16892612 | METHOD FOR ANALYZING NUCLEIC ACID SEQUENCE | June 2020 | November 2022 | Allow | 30 | 2 | 0 | No | Yes |
| 16878791 | PRIMERS, KIT AND METHOD FOR DETECTING EHP PATHOGENS OF LITOPENAEUS VANNAMEI | May 2020 | June 2022 | Abandon | 25 | 1 | 1 | No | No |
| 16870444 | COMPOSITIONS AND METHODS FOR IMPROVED cDNA SYNTHESIS | May 2020 | December 2023 | Abandon | 43 | 4 | 0 | Yes | No |
| 16760296 | NUCLEIC ACID QUANTIFICATION METHOD USING STABLE ISOTOPE-LABELLED NUCLEIC ACID AS INTERNAL STANDARD AND USE OF THE SAME | April 2020 | August 2023 | Abandon | 40 | 4 | 0 | Yes | No |
| 16756198 | DRY COMPOSITIONS FOR USE IN NUCLEIC ACID AMPLIFICATION AND METHODS | April 2020 | June 2022 | Abandon | 26 | 1 | 1 | No | No |
| 16650677 | Onion Discrimination Method | March 2020 | September 2022 | Allow | 30 | 4 | 1 | Yes | No |
| 16649659 | A METHOD OF AMPLIFYING A TARGET NUCLEIC ACID | March 2020 | January 2023 | Allow | 34 | 2 | 0 | No | No |
| 16823731 | METHODS AND COMPOSITIONS FOR PREPARING POLYNUCLEOTIDES | March 2020 | February 2023 | Allow | 35 | 2 | 0 | No | No |
| 16816627 | METHODS OF DETECTING MINIMAL RESIDUAL DISEASE | March 2020 | July 2022 | Abandon | 28 | 1 | 0 | No | No |
| 16809280 | STABILIZED REDUCING AGENTS AND METHODS USING SAME | March 2020 | September 2021 | Abandon | 19 | 0 | 1 | No | No |
| 16801254 | PHASE-PROTECTING REAGENT FLOW ORDERINGS FOR USE IN SEQUENCING-BY-SYNTHESIS | February 2020 | March 2022 | Allow | 25 | 2 | 1 | No | No |
| 16639662 | METHODS AND KITS FOR DETECTION OF NUCLEIC ACID MOLECULES | February 2020 | February 2024 | Abandon | 48 | 5 | 1 | Yes | No |
| 16639422 | METHOD AND COMPOSITIONS FOR EVALUATING EMULSION UNIFORMITY | February 2020 | July 2023 | Abandon | 41 | 3 | 0 | No | No |
| 16789287 | METHODS FOR PROCESSING NUCLEIC ACID MOLECULES | February 2020 | October 2022 | Allow | 32 | 2 | 0 | No | No |
| 16637076 | METHOD FOR EVALUATING RISK OF HEPATOCELLULAR CARCINOMA | February 2020 | August 2023 | Abandon | 43 | 3 | 0 | No | No |
| 16752875 | DNA SEQUENCING | January 2020 | February 2022 | Allow | 25 | 2 | 1 | No | No |
| 16633731 | METHOD OF ISOLATING NUCLEIC ACID | January 2020 | May 2023 | Abandon | 40 | 2 | 2 | No | No |
| 16750319 | CHIMERIC PRIMERS WITH HAIRPIN CONFORMATIONS AND METHODS OF USING SAME | January 2020 | January 2022 | Allow | 23 | 2 | 0 | No | No |
| 16749731 | METHODS OF NUCLEIC ACID DETECTION AND PRIMER DESIGN | January 2020 | December 2023 | Abandon | 47 | 4 | 0 | Yes | No |
| 16720065 | METHODS FOR DETECTING VARIANT NUCLEOTIDES | December 2019 | May 2023 | Abandon | 41 | 3 | 0 | No | Yes |
| 16624782 | PCR PRIMER PAIR AND APPLICATION THEREOF | December 2019 | June 2024 | Allow | 54 | 3 | 1 | No | Yes |
| 16719031 | DNA SEQUENCING | December 2019 | July 2022 | Abandon | 30 | 2 | 1 | No | No |
| 16717704 | Methods And Kits For Detecting A Prostate Carcinoma And Predicting Disease Outcomes For Prostate Cancers | December 2019 | August 2022 | Abandon | 32 | 1 | 0 | No | No |
| 16622122 | RT-QPCR METHOD FOR DIRECT QUANTITATIVE DETECTION OF CIRCULATING MIRNA | December 2019 | November 2022 | Abandon | 35 | 2 | 0 | No | No |
| 16706243 | Assay for the Rapid Detection of Nucleic Acids via a Modified LAMP Reaction Coupled with Colorimetric Reporter Utilizing a Gold Nanoparticle Peptide Nucleic Acid AuNP-PNA Probe System | December 2019 | August 2022 | Abandon | 33 | 2 | 0 | No | No |
| 16703190 | METHODS FOR MULTIPLEXING RECOMBINASE POLYMERASE AMPLIFICATION | December 2019 | September 2022 | Allow | 34 | 2 | 0 | No | No |
| 16700824 | Polynucleotides for Amplification and Detection of Human Beta Actin | December 2019 | September 2023 | Allow | 46 | 2 | 1 | No | No |
| 16693211 | SYSTEM AND KIT FOR DETECTING THE NUMBER OF CGG REPEATS IN THE 5' UNTRANSLATED REGION OF FMR1 GENE | November 2019 | May 2024 | Abandon | 53 | 5 | 1 | No | No |
| 16688531 | METHOD FOR SUPPRESSING NON-SPECIFIC AMPLIFICATION PRODUCTS IN NUCLEIC ACID AMPLIFICATION TECHNOLOGIES | November 2019 | December 2023 | Abandon | 48 | 4 | 1 | Yes | No |
| 16658029 | Pyrophosphorolysis activated fluorescence to measure PAP amplification of nucleic acid | October 2019 | January 2024 | Allow | 51 | 5 | 0 | Yes | No |
| 16595167 | METHODS FOR PERFORMING MULTIPLEXED REAL-TIME PCR | October 2019 | September 2021 | Allow | 23 | 1 | 0 | No | No |
| 16590878 | METHODS OF PREPARING NUCLEIC ACIDS FOR SEQUENCING | October 2019 | June 2023 | Allow | 45 | 4 | 0 | Yes | No |
| 16588405 | DETERMINING 5' TRANSCRIPT SEQUENCES | September 2019 | January 2023 | Allow | 39 | 4 | 1 | No | No |
| 16569081 | AMPLIFICATION METHOD OF A SINGLE STRANDED DNA | September 2019 | March 2023 | Abandon | 42 | 3 | 1 | Yes | No |
| 16492262 | NUCLEIC ACID ENZYME-MEDIATED SIGNAL AMPLIFICATION FOR BIOSENSING | September 2019 | June 2024 | Abandon | 58 | 5 | 1 | Yes | No |
| 16492084 | EASY ONE-STEP AMPLIFICATION AND LABELING (EOSAL) | September 2019 | October 2021 | Abandon | 25 | 0 | 1 | No | No |
| 16553667 | Method of enhancing isothermal amplification sensitivity of nucleic acid and reagents thereof | August 2019 | November 2023 | Abandon | 51 | 4 | 1 | No | No |
| 16543211 | Multiplex Preparation of Barcoded Gene Specific DNA Fragments | August 2019 | January 2022 | Allow | 29 | 2 | 1 | No | No |
| 16485187 | PCR PRIMER SET FOR HLA GENE, AND SEQUENCING METHOD USING SAME | August 2019 | January 2022 | Abandon | 30 | 1 | 1 | No | No |
| 16519506 | DETECTION OF TARGETED SEQUENCE REGIONS | July 2019 | April 2022 | Allow | 33 | 2 | 0 | No | No |
| 16474510 | REAGENT FOR USE IN ASSESSMENT OF REMAINING VERY SMALL LESION OF NEUROBLASTOMA; AND METHOD FOR ANALYZING BIOLOGICAL SAMPLE USING SAME | June 2019 | July 2022 | Abandon | 37 | 2 | 1 | No | No |
| 16473020 | METHOD FOR DIAGNOSING LUNG CANCER VIA BACTERIAL METAGENOMIC ANALYSIS | June 2019 | November 2023 | Abandon | 52 | 5 | 1 | No | No |
| 16434652 | METHOD AND SYSTEM FOR DIFFERENTIATING MORE PATHOGENIC STAPHYLOCOCCUS STRAINS | June 2019 | February 2022 | Abandon | 32 | 1 | 1 | No | No |
| 16414672 | PRIMER PAIR, KIT AND METHOD OF DETECTING BABESIA CANIS | May 2019 | November 2022 | Abandon | 42 | 2 | 0 | No | No |
| 16349892 | NON-UNIQUE BARCODES IN A GENOTYPING ASSAY | May 2019 | September 2024 | Abandon | 60 | 7 | 0 | No | No |
| 16345733 | STR BASED RAPID PERSONAL IDENTIFICATION | April 2019 | September 2021 | Abandon | 28 | 0 | 1 | No | No |
| 16370329 | METHOD FOR OBTAINING BASE SEQUENCE INFORMATION OF SINGLE CELL DERIVED FROM VERTEBRATE | March 2019 | October 2021 | Abandon | 30 | 1 | 0 | No | No |
| 16370342 | METHOD FOR DETERMINING ORIGIN OF HUMAN GENOMIC DNA OF 100 PG OR LESS, METHOD FOR IDENTIFYING INDIVIDUAL, AND METHOD FOR ANALYZING LEVEL OF ENGRAFTMENT OF HEMATOPOIETIC STEM CELLS | March 2019 | October 2021 | Abandon | 31 | 1 | 0 | No | No |
| 16099953 | POLYNUCLEOTIDE ENRICHMENT AND AMPLIFICATION USING CRISPR-CAS OR ARGONAUTE SYSTEMS | March 2019 | September 2022 | Allow | 46 | 4 | 0 | Yes | No |
| 16352083 | DIRECT-TO-CONSUMER GENOMIC DIAGNOSTIC DEVICE | March 2019 | February 2022 | Abandon | 35 | 1 | 1 | Yes | No |
| 16284030 | METHODS FOR DETERMINING A NUCLEOTIDE SEQUENCE | February 2019 | October 2022 | Abandon | 43 | 2 | 1 | No | No |
| 16321418 | Methods of Producing Amplified Double Stranded Deoxyribonucleic Acids and Compositions and Kits for Use Therein | January 2019 | July 2022 | Allow | 41 | 4 | 1 | Yes | No |
| 16224617 | ENHANCED NUCLEIC ACID IDENTIFICATION AND DETECTION | December 2018 | April 2022 | Allow | 40 | 2 | 0 | Yes | No |
| 16223751 | DNA SEQUENCING | December 2018 | December 2023 | Abandon | 60 | 6 | 1 | Yes | No |
| 16224444 | ITERATIVE NUCLEIC ACID ASSEMBLY USING ACTIVATION OF VECTOR-ENCODED TRAITS | December 2018 | June 2023 | Abandon | 53 | 3 | 1 | Yes | No |
| 16167893 | OPTIMIZED REAL-TIME NUCLEIC ACID DETECTION PROCESSES | October 2018 | January 2022 | Abandon | 39 | 2 | 0 | No | No |
| 16161203 | DETECTION ACCURACY IDENTIFYING METHOD, DETECTION ACCURACY IDENTIFYING DEVICE, AND NON-TRANSITORY RECORDING MEDIUM STORING DETECTION ACCURACY IDENTIFYING PROGRAM | October 2018 | July 2024 | Abandon | 60 | 4 | 1 | Yes | No |
| 16155133 | RECOMBINASE POLYMERASE AMPLIFICATION | October 2018 | February 2022 | Allow | 40 | 1 | 1 | No | No |
| 16143085 | METHODS AND NUCLEIC ACIDS FOR ANALYSES OF CELLULAR PROLIFERATIVE DISORDERS | September 2018 | April 2024 | Abandon | 60 | 5 | 1 | No | Yes |
| 16088230 | Polarization-Based Fluorescent Nucleic Acid Detection | September 2018 | June 2023 | Abandon | 56 | 2 | 1 | No | No |
| 16079432 | LEUKEMIA DIAGNOSTIC KIT TARGETING PROHIBITIN GENE AND DIAGNOSTIC METHOD USING SAME | August 2018 | March 2022 | Allow | 43 | 2 | 1 | No | No |
| 16057670 | Direct Capture, Amplification and Sequencing of Target DNA Using Immobilized Primers | August 2018 | August 2020 | Abandon | 24 | 2 | 0 | No | No |
| 16048975 | SYSTEM AND METHOD FOR CAPTURING AND ANALYZING CELLS | July 2018 | March 2022 | Allow | 43 | 7 | 0 | Yes | No |
| 15973243 | DIGITAL ASSAYS WITH A GENERIC REPORTER | May 2018 | February 2022 | Allow | 46 | 3 | 0 | No | Yes |
| 15941057 | ENDONUCLASE-ASSISTED ISOTHERMAL AMPLIFICATION USING CONTAMINATION-FREE REAGENTS | March 2018 | October 2021 | Allow | 43 | 2 | 1 | No | No |
| 15867115 | MEMBRANE ASSAY METHOD | January 2018 | April 2022 | Allow | 51 | 4 | 0 | No | No |
| 15740255 | PROBES AND A METHYLATION IN SITU HYBRIDIZATION ASSAY | December 2017 | July 2019 | Abandon | 18 | 0 | 1 | No | No |
| 15738821 | BIOSENSOR COMPRISING TANDEM REACTIONS OF STRUCTURE SWITCHING, NUCLEOLYTIC DIGESTION AND AMPLIFICATION OF A NUCLEIC ACID ASSEMBLY | December 2017 | December 2019 | Abandon | 24 | 1 | 1 | No | No |
| 15815230 | AMPLICON MELTING ANALYSIS WITH SATURATION DYES | November 2017 | November 2020 | Abandon | 36 | 4 | 0 | Yes | No |
| 15798696 | SEQUENCE, TECHNIQUE PLATFORM, AND METHOD FOR IN VITRO DETECTING CLOSTRIDIUM DIFFICILE RIBOTYPE 027 | October 2017 | February 2022 | Abandon | 52 | 4 | 0 | Yes | No |
| 15784929 | Methods and Compositions for Rapid Multiplex Application of STR LOCI | October 2017 | January 2021 | Allow | 39 | 2 | 0 | Yes | No |
| 15566718 | Method for Analysing Nuclease Hypersensitive Sites | October 2017 | August 2024 | Abandon | 60 | 6 | 1 | No | Yes |
| 15705821 | METHODS FOR PERFORMING MULTIPLEXED REAL-TIME PCR | September 2017 | March 2021 | Allow | 42 | 3 | 1 | No | No |
| 15705772 | METHODS FOR PERFORMING MULTIPLEXED PCR | September 2017 | February 2021 | Allow | 41 | 3 | 0 | No | No |
| 15704159 | SIMULTANEOUS SEQUENCING OF RNA AND DNA FROM THE SAME SAMPLE | September 2017 | June 2020 | Abandon | 33 | 0 | 1 | No | No |
| 15691279 | HIGH THROUGHPUT NUCLEIC ACID SEQUENCING BY EXPANSION AND RELATED METHODS | August 2017 | October 2019 | Abandon | 26 | 1 | 0 | No | No |
| 15689120 | DUAL POLARITY ANALYSIS OF NUCLEIC ACIDS | August 2017 | July 2020 | Abandon | 34 | 3 | 0 | No | No |
| 15658041 | METHODS AND MATERIALS FOR CAPTURE ANTIBODY TARGETED FLUORESCENT IN-SITU HYBRIDIZATION (CAT-FISH) | July 2017 | November 2019 | Abandon | 28 | 0 | 1 | No | No |
| 15643860 | RAPID THERMOCYCLER SYSTEM FOR RAPID AMPLIFICATION OF NUCLEIC ACIDS AND RELATED METHODS | July 2017 | July 2019 | Abandon | 24 | 1 | 0 | No | No |
| 15634874 | METHODS FOR MOLECULAR DETECTION | June 2017 | July 2019 | Abandon | 24 | 1 | 0 | No | No |
| 15595353 | METHODS AND COMPOSITIONS FOR NUCLEIC ACID AMPLIFICATION | May 2017 | May 2019 | Allow | 24 | 1 | 0 | No | No |
| 15519133 | ONE-STOP TREATMENT METHOD FOR BREAKING NUCLEIC ACID BY MEANS OF TRANSPOSASE, AND REAGENT | April 2017 | August 2019 | Abandon | 28 | 2 | 1 | No | No |
| 15424830 | MAPPING THE SPATIAL LOCALIZATION OF CELLULAR NUCLEIC ACIDS BY PROXIMITY-DEPENDENT ENZYMATIC TAGGING | February 2017 | July 2020 | Abandon | 41 | 2 | 0 | No | No |
| 15417736 | METHODS AND COMPOSITIONS FOR NUCLEIC ACID AMPLIFICATION | January 2017 | June 2019 | Allow | 28 | 1 | 0 | No | No |
| 15319422 | DETECTION OF A SOURCE OF PINK DISCOLORATION DEFECT IN A SAMPLE | December 2016 | August 2019 | Abandon | 32 | 1 | 1 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner CHUNDURU, SURYAPRABHA.
With a 58.1% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 24.8% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner CHUNDURU, SURYAPRABHA works in Art Unit 1637 and has examined 711 patent applications in our dataset. With an allowance rate of 33.5%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 40 months.
Examiner CHUNDURU, SURYAPRABHA's allowance rate of 33.5% places them in the 6% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by CHUNDURU, SURYAPRABHA receive 2.79 office actions before reaching final disposition. This places the examiner in the 78% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by CHUNDURU, SURYAPRABHA is 40 months. This places the examiner in the 23% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +31.5% benefit to allowance rate for applications examined by CHUNDURU, SURYAPRABHA. This interview benefit is in the 78% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 11.1% of applications are subsequently allowed. This success rate is in the 7% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 26.7% of cases where such amendments are filed. This entry rate is in the 38% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.
When applicants request a pre-appeal conference (PAC) with this examiner, 62.9% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 52% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.
This examiner withdraws rejections or reopens prosecution in 66.3% of appeals filed. This is in the 47% percentile among all examiners. Of these withdrawals, 54.1% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.
When applicants file petitions regarding this examiner's actions, 66.7% are granted (fully or in part). This grant rate is in the 70% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.
Examiner's Amendments: This examiner makes examiner's amendments in 2.5% of allowed cases (in the 78% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.8% of allowed cases (in the 61% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.